HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism.

AbstractBACKGROUND:
Recombinant-FSH (rFSH) added to hCG at dose of 450 IU weekly is effective in inducing spermatogenesis in patients with hypogonadotropic hypogonadism (HH), but there are no data on the use of lower doses.
AIM:
This observational retrospective study evaluated whether 150-225 IU of rFSH weekly were able to induce spermatogenesis in HH men who failed to start it with hCG alone.
SUBJECTS AND METHODS:
Thirty-four patients with pre-pubertal onset HH (20-44 yr old) without adverse fertility factors were considered for this study. After hCG pre-treatment they received also either rFSH (Group 1) or highly purified urinary FSH (hpFSH) (Group 2) 75 IU sc 2 or 3 times weekly. Semen analysis was performed every 3 months during pre-treatment and the 1st yr of combined therapy. Patients were also invited to refer pregnancies in their partners during the subsequent 12 months.
RESULTS:
Total sperm count/ejaculate did not show significant difference between 2 groups, while a significantly higher forward motility was observed in Group 1 (p<0.05). The median times to achieve sperm output thresholds (first sperm appearance, sperm concentration >1.5 or >5 mil/ml) were significantly lower in Group 1 (p<0.04, 0.03, and 0.001, respectively). A tendency to a shorter time to pregnancy was shown in partners of Group 1.
CONCLUSIONS:
Our data indicate that lower rFSH week dose than that so far used was able to induce potentially fertilizing sperm output in HH men previously treated with hCG. The rFSH effects are comparable to those of hpFSH but with a trend to a faster outcome achievement.
AuthorsA A Sinisi, D Esposito, G Bellastella, L Maione, V Palumbo, L Gandini, F Lombardo, A De Bellis, A Lenzi, A Bellastella
JournalJournal of endocrinological investigation (J Endocrinol Invest) Vol. 33 Issue 9 Pg. 618-23 (Oct 2010) ISSN: 1720-8386 [Electronic] Italy
PMID20436264 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Follicle Stimulating Hormone, Human
  • Recombinant Proteins
Topics
  • Adult
  • Dose-Response Relationship, Drug
  • Female
  • Fertility (drug effects)
  • Follicle Stimulating Hormone, Human (administration & dosage)
  • Humans
  • Hypogonadism (complications, drug therapy, physiopathology)
  • Infertility, Male (complications, drug therapy, physiopathology)
  • Male
  • Pregnancy
  • Recombinant Proteins (administration & dosage)
  • Retrospective Studies
  • Sperm Count
  • Spermatogenesis (drug effects)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: